Skip to Content

Irbesartan Hydrochlorothiazide BMS

Active Substance: irbesartan / hydrochlorothiazide
Common Name: irbesartan / hydrochlorothiazide
ATC Code: C09DA04
Marketing Authorisation Holder: Bristol-Myers Squibb Pharma EEIG
Active Substance: irbesartan / hydrochlorothiazide
Status: Withdrawn
Authorisation Date: 2007-01-19
Therapeutic Area: Hypertension
Pharmacotherapeutic Group: Agents acting on the renin-angiotensin system

Therapeutic Indication

Treatment of essential hypertension.
This fixed dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone (see section 5.1).

The marketing authorisation for Irbesartan Hydrochlorothiazide BMS has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide